AMG_IMG_Bispecific Antibodies - Modality
Loading ...

Leadership Team

Select the fields to be shown. Others will be hidden. Drag and drop to rearrange the order.
  • Image
  • SKU
  • Rating
  • Price
  • Stock
  • Availability
  • Add to cart
  • Description
  • Content
  • Weight
  • Dimensions
  • Additional information
Click outside to hide the comparison bar
Compare

Dr. Frank Li

CEO

Dr. Li is a highly acclaimed biotech leader, recognized for driving growth and innovation at Alliance Pharma. A recipient of multiple Top 100 Fast Growing Company and Future 50 CEO awards, he has advanced bioanalytical services and set new industry benchmarks, earning broad respect across the pharmaceutical and biotech sectors.

Dr. Xianxin Hua

Co-founder

Dr. Hua is a pioneering researcher with over 100 publications and groundbreaking innovations, including the STAR system and CAR-T therapies (CDH17CART, Phase I/II). His discovery of menin inhibition as a treatment for diabetes led to Phase II/III clinical trials (Biomea Fusion). A visionary in translational medicine, he bridges immuno-oncology and metabolic research to drive breakthroughs with global impact.

Dr. Jay Feng

Director

Dr. Feng is a prolific innovator with deep expertise in targeted therapies, including CDH17CART (licensed for clinical trials). He has engineered novel CAR-T platforms using phage display and developed a proprietary system for rapid nanobody isolation, accelerating therapeutic discovery. His work combines precision and scalability to help redefine the future of cancer treatment.